Table 5.

Diagnosis, treatment, and outcomes

	PI-born (n = 92)	US-born (n = 153)	Unadjusted OR, 95%CI
Diagnosis on screening	15 (18%)	29 (28%)	0.57, 0.28–1.15
Locoregional therapy	23 (27%)	75 (51%)	0.36, 0.20–0.63
Ablation	7 (8%)	16 (10%)	0.70, 0.28–1.78
Chemotherapy	2 (2%)	2 (1%)	1.68, 0.23–12.11
Radiation	1 (1%)	1 (1%)	1.67, 0.10–27.03
Surgical intervention (transplant or resection)	16 (18%)	28 (22%)	0.81, 0.42–1.58
Transplant	7 (8%)	4 (3%)	3.03, 0.86–10.64
Resection	9 (10%)	24 (19%)	0.49, 0.22–1.10
Palliative (surgical hemostasis, biliary stent)	3 (3%)	0	12.00, 0.61–235.11
No treatment	40 (43%)	31 (20%)	3.22, 1.77–5.87
Loss to follow-up	10 (11%)	2 (1%)	9.21, 1.97–43.03
1-year survival	51 (62%)	89 (59%)	1.15, 0.66–1.99
3-year survival	36 (44%)	45 (30%)	1.84, 1.05–3.22
5-year survival	31 (38%)	33 (22%)	2.17, 1.20–3.92
Median survival (months)	22.4	16.9

PI-born: Pacific Island-born.